The lack of any significant changes in pennation angle for either group may also be related to resistance training Lazertinib experience, as experience does appear to impact the magnitude of change in pennation angle [31]. There are a number of limitations associated with

this study. The scientific treatise that has emanated on phosphatidic acid and its role on muscle protein synthesis stimulated the desire to examine this further. Although the results of this study provide a BIX 1294 clinical trial degree of efficacy on this novel ingredient, it does not provide any support to the previously discussed mechanisms of action. However, the results of this study do provide some evidence on the proof of concept that PA may have a role in muscle strength and lean tissue accruement. Additional research is needed to add support to these results: a bioavailability study to investigate the absorption profile of orally administered

PA, a muscle biopsy study to investigate the potential increase in muscle PA content, different target groups: trained, untrained, elderly subjects, dose finding studies to investigate if the effect of PA is dose dependent, the minimum effective dose and mechanistic studies. This will have important implications for athletes participating in strength/power sports, as well as mature adults attempting to maintain muscle strength and mass as they age. In conclusion, the results of this study suggest that a combination of a daily 750 mg PA ingestion, combined with a 4-day selleck kinase inhibitor per week resistance training Oxaprozin program

for 8-weeks appears to have a likely benefit on strength improvement, and a very likely benefit on lean tissue accruement in young, resistance trained individuals. Additional research is warranted to provide further elucidation on the mechanisms that govern PA and muscle protein synthesis, muscle growth and performance. Acknowledgements The authors would like to thank a dedicated group of subjects. This study was supported by a grant from Chemi Nutra, White Bear Lake, MN. References 1. Hanahan DJ, Nelson DR: Phospholipids as dynamic participants in biological processes. J Lipid Res 1984, 25:1528–1535.PubMed 2. Jäger R, Purpura M, Kingsley M: Phospholipids and sports nutrition. J Int Soc Sports Nutr 2007, 4:5.PubMedCrossRef 3. Singer WD, Brown HA, Sternweis PC: Regulation of eukaryotic phosphatidylinositol-specific phospholipase C and phospholipase D. Annu Rev Biochem 1997, 66:475–509.PubMedCrossRef 4. Lim H, Choi Y, Park W, Lee T, Ryu S, Kim S, Kim JR, Kim JH, Baek S: Phosphatidic acid regulates systemic inflammatory responses by modulationg the Akt-mamalian target of rapamycin-p70 S6 Kinase pathway. J Bio Chem 2003,2003(278):45117–45127.CrossRef 5. Andresen BT, Rizzo MA, Shome K, Romero G: The role of phosphatidic acid in the regulation of the Ras/MEK/Erk signaling cascade. FEBS Lett 2002, 531:65–68.PubMedCrossRef 6.